175 related articles for article (PubMed ID: 16585156)
1. Akt-mediated phosphorylation and activation of estrogen receptor alpha is required for endometrial neoplastic transformation in Pten+/- mice.
Vilgelm A; Lian Z; Wang H; Beauparlant SL; Klein-Szanto A; Ellenson LH; Di Cristofano A
Cancer Res; 2006 Apr; 66(7):3375-80. PubMed ID: 16585156
[TBL] [Abstract][Full Text] [Related]
2. Gene expression analysis reveals a signature of estrogen receptor activation upon loss of Pten in a mouse model of endometrial cancer.
Lian Z; De Luca P; Di Cristofano A
J Cell Physiol; 2006 Aug; 208(2):255-66. PubMed ID: 16688764
[TBL] [Abstract][Full Text] [Related]
3. Endometrial tumorigenesis in Pten(+/-) mice is independent of coexistence of estrogen and estrogen receptor α.
Joshi A; Wang H; Jiang G; Douglas W; Chan JS; Korach KS; Ellenson LH
Am J Pathol; 2012 Jun; 180(6):2536-47. PubMed ID: 22503752
[TBL] [Abstract][Full Text] [Related]
4. Estrogen affects the negative feedback loop of PTENP1-miR200c to inhibit PTEN expression in the development of endometrioid endometrial carcinoma.
Chen R; Zhang M; Liu W; Chen H; Cai T; Xiong H; Sheng X; Liu S; Peng J; Wang F; Chen H; Lin W; Xu X; Zheng W; Jiang Q
Cell Death Dis; 2018 Dec; 10(1):4. PubMed ID: 30584245
[TBL] [Abstract][Full Text] [Related]
5. Mutual contribution of Pten and estrogen to endometrial carcinogenesis in a PtenloxP/loxP mouse model.
Saito F; Tashiro H; To Y; Ohtake H; Ohba T; Suzuki A; Katabuchi H
Int J Gynecol Cancer; 2011 Nov; 21(8):1343-9. PubMed ID: 21989218
[TBL] [Abstract][Full Text] [Related]
6. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].
Yang X; Dong Y; Zhang XM; Liang Y; Zhang Y; Meng YT; Wang Y; Wang W; Nong L; Li T; Liao QP
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):799-804. PubMed ID: 22336203
[TBL] [Abstract][Full Text] [Related]
7. Rapid estrogen signaling negatively regulates PTEN activity through phosphorylation in endometrial cancer cells.
Scully MM; Palacios-Helgeson LK; Wah LS; Jackson TA
Horm Cancer; 2014 Aug; 5(4):218-31. PubMed ID: 24844349
[TBL] [Abstract][Full Text] [Related]
8. Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation.
Kim TH; Yoo JY; Kim HI; Gilbert J; Ku BJ; Li J; Mills GB; Broaddus RR; Lydon JP; Lim JM; Yoon HG; Jeong JW
Cancer Res; 2014 Dec; 74(24):7371-82. PubMed ID: 25377472
[TBL] [Abstract][Full Text] [Related]
9. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.
Ge X; Guo R; Qiao Y; Zhang Y; Lei J; Wang X; Li L; Hu D
Int J Gynecol Cancer; 2013 Jan; 23(1):52-9. PubMed ID: 23235274
[TBL] [Abstract][Full Text] [Related]
10. Elevation of ω-3 Polyunsaturated Fatty Acids Attenuates PTEN-deficiency Induced Endometrial Cancer Development through Regulation of COX-2 and PGE2 Production.
Pan J; Cheng L; Bi X; Zhang X; Liu S; Bai X; Li F; Zhao AZ
Sci Rep; 2015 Oct; 5():14958. PubMed ID: 26468779
[TBL] [Abstract][Full Text] [Related]
11. Alteration of PTEN expression in endometrial carcinoma is associated with down-regulation of cyclin-dependent kinase inhibitor, p27.
An HJ; Lee YH; Cho NH; Shim JY; Kim JY; Lee C; Kim SJ
Histopathology; 2002 Nov; 41(5):437-45. PubMed ID: 12405911
[TBL] [Abstract][Full Text] [Related]
12. Relation between outcomes and expression of estrogen receptor-α phosphorylated at Ser(167) in endometrioid endometrial cancer.
Kato E; Orisaka M; Kurokawa T; Chino Y; Fujita Y; Shinagawa A; Yoshida Y
Cancer Sci; 2014 Oct; 105(10):1307-12. PubMed ID: 25154549
[TBL] [Abstract][Full Text] [Related]
13. PI3K/PTEN/AKT Genetic Mouse Models of Endometrial Carcinoma.
Joshi A; Ellenson LH
Adv Exp Med Biol; 2017; 943():261-273. PubMed ID: 27910071
[TBL] [Abstract][Full Text] [Related]
14. Correlation between PTEN expression and PI3K/Akt signal pathway in endometrial carcinoma.
Gao Q; Ye F; Xia X; Xing H; Lu Y; Zhou J; Ma D
J Huazhong Univ Sci Technolog Med Sci; 2009 Feb; 29(1):59-63. PubMed ID: 19224164
[TBL] [Abstract][Full Text] [Related]
15. Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression.
Huang HN; Lin MC; Tseng LH; Chiang YC; Lin LI; Lin YF; Huang HY; Kuo KT
Histopathology; 2015 Mar; 66(4):517-28. PubMed ID: 25195947
[TBL] [Abstract][Full Text] [Related]
16. PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy.
Bian X; Gao J; Luo F; Rui C; Zheng T; Wang D; Wang Y; Roberts TM; Liu P; Zhao JJ; Cheng H
Oncogene; 2018 Jan; 37(3):341-351. PubMed ID: 28945226
[TBL] [Abstract][Full Text] [Related]
17. Role of Tumor Suppressor PTEN and Its Regulation in Malignant Transformation of Endometrium.
Perevalova AM; Kobelev VS; Sisakyan VG; Gulyaeva LF; Pustylnyak VO
Biochemistry (Mosc); 2022 Nov; 87(11):1310-1326. PubMed ID: 36509719
[TBL] [Abstract][Full Text] [Related]
18. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
[TBL] [Abstract][Full Text] [Related]
19. Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer.
Zaczek A; Jóźwiak P; Ciesielski P; Forma E; Wójcik-Krowiranda K; Cwonda Ł; Bieńkiewicz A; Bryś M; Krześlak A
J Cell Mol Med; 2020 Jan; 24(2):1300-1310. PubMed ID: 31863623
[TBL] [Abstract][Full Text] [Related]
20. [Correlations of p-AKT with PTEN, P53, HER-2 expressions in endometrial carcinoma and their relationship with patient survival].
Zhang XM; Liang Y; Dong Y; Zhang Y; Wang Y; Meng YT; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Feb; 44(1):135-41. PubMed ID: 22353917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
